Xora Innovation

AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe. AdBio partners’ unique strategy combines early-stage investments in promising startups and strong entrepreneurial support to enable and strengthen the company’s growth. As an early-stage investor, we act as a catalyst to create companies based on innovations coming from academic research. We have established relationships with leading research institutions and technology transfer offices in Europe and benefit from the support of strong network of scientific, clinical, industry and financial partners. The operational team is managed by Alain Huriez, MD, Chairman and Managing Partner, and Geoffroy de Ribains, Managing Partner. The team includes seasoned investment professionals with long-standing track records in entrepreneurial ventures, combined with strong scientific, medical and operational expertise.

Since its genesis at the University of Oxford in 2015, Panacea Innovation has partnered with some of the world’s best sci-entrepreneurs, research bodies, universities and corporates to build more than 280 companies that offer cutting-edge solutions - curating a portfolio of more than GBP£300m in value. Panacea Innovation’s venturing activities are delivered through two complementary arms: Panacea Stars - a technology translation, commercialisation and R&D arm - and Panacea Ventures, the investment management one.

We invest in visionary science start-ups. As part of the xista ecosystem, set up by the Institute of Science and Technology Austria, xista science ventures speak the language of scientist and investor. This makes us a unique partner to fuel founders’ deep tech ideas and help build exciting, scalable companies. Our understanding of academic spin-offs and the deep tech founders landscape, allows xista science ventures to recognise, analyse and propel companies to the next stage. We encourage the cross-fertilisation of startups to inspire new discoveries. Let us learn and profit from each other.

Since 2006 we’ve backed Yale faculty doing cutting edge research on some of the world’s largest problems. With Yale as our largest investor, we’ve supported teams developing much-needed therapeutics, advanced tools and materials for industry, and critical interventions for a warming planet. Our thesis is that great people and great science lead to great impact. YALE AND NEW HAVEN We are primarily interested in companies with a Yale connection, typically technology developed at and licensed from Yale. We also invest in companies located in the greater New Haven area, and, in exceptional cases, non-Yale/non-New Haven companies in which we have strong, personal connections to the founders or investors or where we can add substantial value. INVESTING IN PEOPLE In making investment decisions, we weigh the strength of the team as much as the technology or markets being addressed – often more. We look for creative thinking, high intelligence, passion, and a deep commitment to working hard for success. Building great businesses takes time and hard work. THERE AT THE START We are interested in investing as early as a good idea comes together, or later, as the team is formed and the business develops. We have been co-founders of a number of our portfolio companies, and find that the most rewarding (and hardest) thing we do. We typically make first investments of $500,000 to $1 million, and, if a company is tracking well, look to invest an additional $2 to $2.5 million over multiple financing rounds. We are happy to syndicate with other investors who share our views and approach to investing.

We use our domain expertise, network, and prior experiences to help our founders scale commercialization, product, and engineering. Post-science project investing We recognize that starting and building a company is hard. Startups by definition are outliers being built by unique collections of humans. We utilize our deep domain expertise to uniquely understand the problems of companies in the categories we care about. Pairing this with our experience working with deep technology, allows us to provide leverage in taking a company from pre, to post-commercialization and building engineering teams across both research and production-level eng.

It's our mission to accelerate a Tough Tech company's journey from ideation to commercialization by providing access to a unique combination of investment, infrastructure, and community. Long-term Capital The Engine Fund provides long-term capital to meet the unique needs of Tough Tech companies solving the world’s most urgent challenges. Labs, Equipment, Tools & Space The Engine Infrastructure provides access to specialized equipment and labs, both on-site and through a network of partner facilities, giving portfolio companies the tools and space necessary to work efficiently and economically. Connections The Engine Network facilitates the creation of long-term mutually beneficial relationships between founders, startups, corporates, government, strategic partners, and others.